Joel Greenblatt Zoetis Inc. Transaction History

Gotham Asset Management, LLC

$16.1 Billion
Q2 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 56,227 shares of ZTS stock, worth $6.76 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

56,227

Previous 17,932 213.56%

Holding current value

$6.76 Million

Previous $2.95 Million 197.02%

% of portfolio

0.05%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$144.41 - $170.3 $5.53 Million - $6.52 Million	38,295 Added 213.56%	56,227 $8.77 Million
Q1 2025 May 15, 2025	BUY	$156.48 - $175.67 $1.56 Million - $1.75 Million	9,959 Added 124.91%	17,932 $2.95 Million
Q4 2024 Feb 14, 2025	BUY	$162.24 - $194.42 $649,284 - $778,068	4,002 Added 100.78%	7,973 $1.3 Million
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $246,099 - $280,180	1,426 Added 56.03%	3,971 $775,000
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $604,718 - $743,038	-4,155 Reduced 62.01%	2,545 $441,000
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $776,163 - $936,718	4,685 Added 232.51%	6,700 $1.13 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $36,648 - $48,421	242 Added 13.65%	2,015 $397,000
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $1.7 Million - $1.96 Million	-10,165 Reduced 85.15%	1,773 $308,000
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $538,505 - $623,125	3,346 Added 38.94%	11,938 $2.06 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $1.62 Million - $1.95 Million	-11,116 Reduced 56.4%	8,592 $1.43 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $46,030 - $55,271	-351 Reduced 1.75%	19,708 $2.89 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $503,741 - $620,122	3,397 Added 20.39%	20,059 $2.98 Million
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $763,473 - $979,440	-4,895 Reduced 22.71%	16,662 $2.86 Million
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $3.32 Million - $4.29 Million	18,312 Added 564.31%	21,557 $4.07 Million
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $525,287 - $669,945	-2,712 Reduced 45.53%	3,245 $792,000
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $956,671 - $1.06 Million	-5,054 Reduced 45.9%	5,957 $1.16 Million
Q2 2021 Aug 16, 2021	SELL	$155.9 - $187.99 $1.92 Million - $2.32 Million	-12,331 Reduced 52.83%	11,011 $2.05 Million
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $333,504 - $392,307	-2,316 Reduced 9.03%	23,342 $3.68 Million
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $1.24 Million - $1.37 Million	7,863 Added 44.19%	25,658 $4.25 Million
Q3 2020 Nov 16, 2020	BUY	$137.1 - $165.37 $2.44 Million - $2.94 Million	17,795 New	17,795 $2.94 Million
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $1.82 Million - $2.09 Million	-15,650 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $35,797 - $40,840	-318 Reduced 1.99%	15,650 $1.95 Million
Q2 2019 Aug 14, 2019	BUY	$97.98 - $114.28 $676,453 - $788,989	6,904 Added 76.17%	15,968 $1.81 Million
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $3.98 Million - $4.92 Million	-48,831 Reduced 84.34%	9,064 $912,000
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $6.17 Million - $7.41 Million	-77,776 Reduced 57.33%	57,895 $4.95 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $22.9 Million - $25.6 Million	-274,186 Reduced 66.9%	135,671 $12.4 Million
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $3.32 Million - $3.71 Million	41,578 Added 11.29%	409,857 $34.9 Million
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $25.9 Million - $30.7 Million	362,667 Added 6462.35%	368,279 $30.8 Million
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $102,701 - $118,227	1,624 Added 40.72%	5,612 $404,000
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $238,203 - $260,815	3,988	3,988 $254,000

Others Institutions Holding ZTS

# of Institutions

2,108

Shares Held

432M

Call Options Held

1.47M

Put Options Held

1.45M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $56.3B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account